Open-Label Study of AXS-07 for the Acute Treatment of Migraine in Adults With a Prior Inadequate Response to an Oral CGRP Inhibitor (EMERGE)
Completed · Phase 3
Conditions studied: Migraine
In brief
This is a multicenter, open-label trial to evaluate the efficacy and safety of AXS-07 in subjects with migraine attacks and prior inadequate response to oral CGRP inhibitors.
Key facts
- Study ID
- NCT05550207
- Run by
- Axsome Therapeutics, Inc.
- People needed
- 100
- Starts
- 2022-08-31
- Expected to finish
- 2024-11-27
- Last updated by the study team
- 2025-12-02
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Has an established diagnosis of migraine with or without aura
- Has experienced an inadequate response to oral CGRP inhibitors for the acute treatment of migraine
You may not qualify if…
- Pregnant, breastfeeding, or planning to become pregnant during the study
- Has previously received any investigational drug or device or investigational therapy within 30 days before Screening
Where it is running
- Clinical Research Site — Colton, California, United States
- Clinical Research Site — Fullerton, California, United States
- Clinical Research Site — La Jolla, California, United States
- Clinical Research Site — Los Angeles, California, United States
- Clinical Research Site — Sherman Oaks, California, United States
- Clinical Research Site — Stamford, Connecticut, United States
- Clinical Research Site — DeLand, Florida, United States
- Clinical Research Site — Hallandale, Florida, United States
- Clinical Research Site — Hollywood, Florida, United States
- Clinical Research Site — Miami, Florida, United States
- Clinical Research Site — Ormond Beach, Florida, United States
- Clinical Research Site — Oviedo, Florida, United States
- Clinical Research Site — Pensacola, Florida, United States
- Clinical Research Site — Winter Park, Florida, United States
- Clinical Research Site — Stockbridge, Georgia, United States
- Clinical Research Site — Avon, Indiana, United States
- Clinical Research Site — Boston, Massachusetts, United States
- Clinical Research Site — North Dartmouth, Massachusetts, United States
- Clinical Research Site — Las Vegas, Nevada, United States
- Clinical Research Site — Albuquerque, New Mexico, United States
- Clinical Research Site — The Bronx, New York, United States
- Clinical Research Site — Williamsville, New York, United States
- Clinical Research Site — Philadelphia, Pennsylvania, United States
- Clinical Research Site — Charleston, South Carolina, United States
- Clinical Research Site — Knoxville, Tennessee, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.